The main side effect of cyclosporine A (CsA), a widely used immunosuppressive drug, is nephrotoxicity. Early detection of CsA-induced acute nephrotoxicity is essential for stop or minimize kidney injury, and timely detection of chronic nephrotoxicity is critical for halting the drug and preventing irreversible kidney injury. This study aimed to identify urinary biomarkers for the detection of CsA-induced nephrotoxicity. We allocated salt-depleted rats to receive CsA or vehicle for 7, 14 or 21 days and evaluated renal function and hemodynamics, microalbuminuria, renal macrophage infiltration, tubulointerstitial fibrosis and renal tissue and urinary biomarkers for kidney injury. Kidney injury molecule-1 (KIM-1), tumor necrosis factor-alpha (T...
Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy...
Cyclosporine (CsA) is a potent immunosuppressant used in the prevention of transplant-ed organ rejec...
Ciclosporin投与ラットでは, 形態学的には近位尿細管上皮細胞の空胞変性が主であったが, dose-relatedではなかった.大量投与群では体重減少, BUNの著明な上昇を認め, catab...
The main side effect of cyclosporine A (CsA), a widely used immunosuppressive drug, is nephrotoxicit...
The calcineurin inhibitor cyclosporine A (CsA) is a widely used immunosuppressive agent. However,nep...
Cyclosporin A (CsA), a calcineurin inhibitor, remain the cornerstone of immunosuppressive regimens, ...
Cyclosporin A (CsA), a calcineurin inhibitor, remain the cornerstone of immunosuppressive regimens, ...
Cyclosporine A (CsA) is a effective and widely used immunosuppressive agent. Nevertheless, its inten...
In recent years, there has been considerable activity to identify urinary biomarkers of nephrotoxici...
A Key for avoiding the negative effects of immunosuppressant caused nephropathy after transplantatio...
Protocols of conversion from cyclosporin A (CsA) to sirolimus (SRL) have been widely used in immunot...
There has been intensive effort to identify in vivo biomarkers that can be used to monitor drug-indu...
There has been intensive effort to identify in vivo biomarkers that can be used to monitor drug-indu...
Side-effect minimization strategies to avoid serious side-effects of cyclosporine A (CsA), such as n...
Cyclosporin (CsA) has been progressively replaced by other drugs with putatively fever side effects,...
Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy...
Cyclosporine (CsA) is a potent immunosuppressant used in the prevention of transplant-ed organ rejec...
Ciclosporin投与ラットでは, 形態学的には近位尿細管上皮細胞の空胞変性が主であったが, dose-relatedではなかった.大量投与群では体重減少, BUNの著明な上昇を認め, catab...
The main side effect of cyclosporine A (CsA), a widely used immunosuppressive drug, is nephrotoxicit...
The calcineurin inhibitor cyclosporine A (CsA) is a widely used immunosuppressive agent. However,nep...
Cyclosporin A (CsA), a calcineurin inhibitor, remain the cornerstone of immunosuppressive regimens, ...
Cyclosporin A (CsA), a calcineurin inhibitor, remain the cornerstone of immunosuppressive regimens, ...
Cyclosporine A (CsA) is a effective and widely used immunosuppressive agent. Nevertheless, its inten...
In recent years, there has been considerable activity to identify urinary biomarkers of nephrotoxici...
A Key for avoiding the negative effects of immunosuppressant caused nephropathy after transplantatio...
Protocols of conversion from cyclosporin A (CsA) to sirolimus (SRL) have been widely used in immunot...
There has been intensive effort to identify in vivo biomarkers that can be used to monitor drug-indu...
There has been intensive effort to identify in vivo biomarkers that can be used to monitor drug-indu...
Side-effect minimization strategies to avoid serious side-effects of cyclosporine A (CsA), such as n...
Cyclosporin (CsA) has been progressively replaced by other drugs with putatively fever side effects,...
Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy...
Cyclosporine (CsA) is a potent immunosuppressant used in the prevention of transplant-ed organ rejec...
Ciclosporin投与ラットでは, 形態学的には近位尿細管上皮細胞の空胞変性が主であったが, dose-relatedではなかった.大量投与群では体重減少, BUNの著明な上昇を認め, catab...